West Pharmaceutical Services Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Good morning. This is Paul Knight, Analyst at Keybanc Capital Markets on the Life Science Industry. We have with us today West Pharmaceutical, Eric Green, CEO; Bernard Birkett, Chief Financial Officer; and Quintin Lai, who's Director of Investor Relations.
The format is going to be -- I think Eric is going to have a few opening comments. If you have questions, you can ask them any time. There's a chat you can put those questions into or on my e-mail [email protected].
And with that, Eric, we appreciate your time today. And I'll let you start it off.
Yes. Great. Well, good morning, Paul, and good morning, everyone. Thank you for the invitation to be able to come together and talk about West and where we are, but more importantly, where we're going. It's an exciting time here at West. Obviously, we'll probably talk a little bit further in the Q&A session around the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |